Cost Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Sarcomas or GI Stromal Tumors

PURPOSE: The value of screening for hepatitis B virus (HBV) infection before chemotherapy for nonhematopoietic solid tumors remains unsettled. We evaluated the cost effectiveness of universal screening before systemic therapy for sarcomas, including GI stromal tumors (GISTs). PATIENTS AND METHODS: D...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Glorijoy, Zhou, Ke, Tan, Chee Hian, Matchar, David B., Farid, Mohamad, Quek, Richard, Ngeow, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2016
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497623/
https://www.ncbi.nlm.nih.gov/pubmed/28717701
http://dx.doi.org/10.1200/JGO.2015.001669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497623/
https://www.ncbi.nlm.nih.gov/pubmed/28717701
http://dx.doi.org/10.1200/JGO.2015.001669

Ejemplares similares